According to filings with the U.S. Securities and Exchange Commission, Autonomix Medical, Inc is raising $20,000,000.00 in new funding. About Autonomix Medical, Inc: Autonomix Medical, Inc. is a medical device company focused on advancing innovative technologies to revolutionize the way diseases involving the peripheral nervous system are diagnosed and treated. The Companys first-in-class technology platform includes a catheter-based microchip sensing array that has the ability to detect and differentiate peripheral neural signals with up to 1,000 times greater sensitivity than currently available technologies. We believe this will enable, for the first time ever, transvascular diagnosis and treatment of diseases involving the peripheral nervous system virtually anywhere in the body. We are initially developing our technology for pancreatic cancer and pancreatitis, conditions that can cause debilitating pain and need an effective solution. However, our technology constitutes a platform with the potential to address dozens of indications, including in cardiology, renal denervation and chronic pain management across a wide disease spectrum.

To learn more about Autonomix Medical, Inc, visit http://autonomix.com/

Contact:
Lori Bisson, Chief Executive Officer
713-588-6150
https://www.linkedin.com/in/lori-bisson-houstx/

SOURCE: http://www.intelligence360.io
Copyright (c) 2023 SI360 Inc. All rights reserved.